Mizuho Securities’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10
Closed -$1.11K 53
2025
Q2
$1.11K Buy
+10
New +$1.06K ﹤0.01% 49
2024
Q1
Sell
-40
Closed -$3.24K 68
2023
Q4
$3.24K Buy
+40
New +$3.11K 0.01% 71
2023
Q1
Sell
-650
Closed -$55.8K 78
2022
Q4
$55.8K Sell
650
-526
-45% -$41.7K 0.16% 53
2022
Q3
$73K Buy
1,176
+879
+296% +$55.4K 0.02% 61
2022
Q2
$22K Buy
297
+131
+79% +$8.11K ﹤0.01% 83
2022
Q1
$10K Buy
166
+68
+69% +$4.35K ﹤0.01% 106
2021
Q4
$7K Sell
98
-10
-9% -$689 ﹤0.01% 108
2021
Q3
$8K Buy
108
+9
+9% +$632 ﹤0.01% 104
2021
Q2
$7K Buy
99
+3
+3% +$200 ﹤0.01% 124
2021
Q1
$6K Buy
96
+66
+220% +$4.26K ﹤0.01% 118
2020
Q4
$2K Buy
+30
New +$1.81K ﹤0.01% 166
2020
Q1
Sell
-1,200
Closed -$78K 74
2019
Q4
$78K Buy
1,200
+580
+94% +$37.8K 0.04% 93
2019
Q3
$39K Buy
+620
New +$40.5K 0.03% 117
2019
Q1
Sell
-850
Closed -$53K 128
2018
Q4
$53K Buy
+850
New +$59.4K ﹤0.01% 69

Other funds holding GILD

Mizuho Securities's GILD Position: Q3 2025 in Review

Mizuho Securities sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 10 shares — an estimated $1.11K sold.

Mizuho Securities first reported a position in GILD in Q4 2018 and held it in 14 quarters. The position peaked at $78K in Q4 2019. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Mizuho Securities reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Mizuho Securities sold 10 Gilead Sciences shares in Q3 2025, an estimated $1.11K.
  • Mizuho Securities first reported a position in Gilead Sciences in Q4 2018 and held it in 14 quarters.
  • Mizuho Securities's Gilead Sciences position peaked at $78K in Q4 2019.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Mizuho Securities's 13F filing for Q3 2025, filed 30 Oct 2025.